Pregabalin BID [twice daily] open-label add-on trial: a follow-up study to determine long-term safety and efficacy in patients with partial seizures
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Pregabalin (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- 06 Mar 2006 Status changed from in progress to completed.
- 20 Nov 2005 New trial record.